Boehringer Ingelheim Limited

Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS
Telephone: +44 (0)1344 424 600
Fax: +44 (0)1344 741 298
WWW: http://www.boehringer-ingelheim.co.uk
Medical Information Direct Line: +44 (0)1344 741 286
Medical Information e-mail: medinfo@bra.boehringer-ingelheim.com

Patient Information Leaflet last updated on the eMC: 01/03/2011
PIL Atrovent Inhaler CFC-free

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/03/2011 and displayed until Current
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to side-effects
  • Change to information about driving or using machinery
Updated on 05/11/2010 and displayed until 01/03/2011
Reasons for adding or updating:
  • Change to how the medicine works
Updated on 16/09/2010 and displayed until 05/11/2010
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
Updated on 13/07/2010 and displayed until 16/09/2010
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
Updated on 17/09/2008 and displayed until 13/07/2010
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 16/05/2007 and displayed until 17/09/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 09/05/2006 and displayed until 16/05/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 04/05/2004 and displayed until 09/05/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   ipratropium bromide monohydrate